Investor Relations

2025-03-14
INSIDE INFORMATION - ISSUANCE OF FILING NOTICE BY THE CSRC FOR THE H SHARE FULL CIRCULATION OF CERTAIN UNLISTED SHARES OF THE COMPANY
2025-03-13
DATE OF BOARD MEETING
2025-03-06
VOLUNTARY ANNOUNCEMENT - APPROVAL BY THE NMPA FOR CLINICAL TRIAL OF IMM01 (TIMDARPACEPT) COMBINED WITH IMM2510 (PALVERAFUSP) AND WITH OR WITHOUT CHEMOTHERAPY FOR ADVANCED MALIGNANT TUMORS
2025-03-05
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2025
2025-02-21
COMPLETION OF DISCLOSEABLE TRANSACTION - DISPOSAL OF EQUITY INTEREST IN A SUBSIDIARY
2025-02-17
(REVISED) SUPPLEMENTAL ANNOUNCEMENT - DISCLOSEABLE TRANSACTION IN RELATION TO THE DISPOSAL OF A SUBSIDIARY
2025-02-06
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2025
2025-01-24
ARTICLES OF ASSOCIATION
2025-01-24
AMENDMENTS TO THE ARTICLES OF ASSOCIATION
2025-01-13
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN THE PHASE IB/II CLINICAL TRIAL OF IMM2510 IN COMBINATION WITH CHEMOTHERAPY FOR THE FIRST-LINE TREATMENT OF NSCLC
2025-01-10
SUPPLEMENTAL ANNOUNCEMENT - DISCLOSEABLE TRANSACTION IN RELATION TO THE DISPOSAL OF A SUBSIDIARY
2025-01-09
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
2025-01-07
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2024
2024-12-30
DISCLOSEABLE TRANSACTION - DISPOSAL OF EQUITY INTEREST IN A SUBSIDIARY
2024-12-17
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN THE PHASE IB CLINICAL TRIAL OF IMM0306 FOR THE TREATMENT OF NMOSD
2024-12-05
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2024
2024-12-02
VOLUNTARY ANNOUNCEMENT - APPROVAL BY THE NMPA FOR A PHASE II CLINICAL TRIAL OF IMM0306 FOR THE TREATMENT OF LUPUS NEPHRITIS
2024-11-28
Next Day Disclosure Return
2024-11-28
COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATE
2024-11-21
PLACING OF NEW H SHARES UNDER GENERAL MANDATE
总计 118 123456